CIK 0001360214 · Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450567010
- Phone
- 615.733.4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement · Acquisition or sale completed
- 8-K Event Results of operations · Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 8-K Event Material agreement · Unregistered share sale
- 4 Open-market buy Director bought 100,000 shares at $1.79 ($179,000)
- 4 Open-market buy Chief Financial Officer bought 39,000 shares at $1.79 ($69,810)
- 4 Open-market buy Chief Executive Officer bought 156,000 shares at $1.79 ($279,240)
- 8-K Event Results of operations · Regulation FD disclosure
Page 26 of 44 · 872 filings